Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.

Basic Information

ID: ALA1143984

Journal: Bioorg Med Chem

Title: Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.

Authors: Uckun FM, Tibbles H, Ozer Z, Qazi S, Vassilev A.

Abstract: We examined the biologic activity of the rationally designed JAK3 inhibitor, JANEX-1, in several cellular and animal models of inflammation. Notably, JANEX-1 exhibited potent anti-inflammatory activity in each of these preclinical models, including mouse models of peritonitis, colitis, cellulitis, and systemic inflammatory response syndrome. Therefore, JANEX-1 may prove useful as a broad-spectrum anti-inflammatory agent. The present study may provide the basis for new and effective treatment as well as prevention programs for inflammatory disorders.

CiteXplore: 18024136

DOI: 10.1016/j.bmc.2007.10.066

Patent ID: